Myriam Gharib
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Immune Cell Function and Interaction, CAR-T cell therapy research, T-cell and B-cell Immunology, COVID-19 Clinical Research Studies
Most-Cited Works
- → Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots(2005)110 cited
- → A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)(2012)24 cited
- → Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours(2017)11 cited
- → Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.(2015)1 cited
- [Effects of LAK cells activated by IL-2 on MCF-7 human breast cancer cell line maintained in organotypic culture].(1993)
- Interactions des cellules lak (lymphokine activated killers) avec des nodules tumoraux maintenus en culture organotypique : proliferation et mort cellulaire(1995)
- → EFFECTS OF LYMPHOKINE-ACTIVATED KILLER-CELLS ON MELANOMA NODULES MAINTAINED IN 3-DIMENSIONAL CULTURE(1995)